Dendritic Polyglycerol Sulfate for Therapy and Diagnostics

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Dendritic polyglycerol sulfate (dPGS) has originally been investigated as an anticoagulant to potentially substitute for the natural glycosaminoglycan heparin. Compared to unfractionated heparin, dPGS possesses lower anticoagulant activity but a much higher anticomplementary effect. Since coagulation, complement activation, and inflammation are often present in the pathophysiology of numerous diseases, dPGS polymers with both anticoagulant and anticomplementary activities represent promising candidates for the development of polymeric drugs of nanosized architecture. In this review, we describe the nanomedical applications of dPGS based on its anti-inflammatory activity. Furthermore, the application of dPGS as a carrier molecule for diagnostic molecules and therapeutic drugs is reviewed, based on the ability to target tumors and localize in tumor cells. Finally, the application of dPGS for inhibition of virus infections is described.
Funding Information
  • Deutsche Forschungsgemeinschaft (SFB 765)
  • Helmholtz-Gemeinschaft (Helmholtz Virtual Institute on “Multifunctional Biomaterials for Medicine”)

This publication has 62 references indexed in Scilit: